6,150
Participants
Start Date
May 6, 2021
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
Colchicine 0.5 MG Oral Tablet
"Colchicine 0.5 mg tablet daily~Active drug and placebo are of the same appearance and are indistinguishable. All investigators, study personnel and patients will be blinded to drug treatment assignment. Trial treatment supplies must be stored in a secure, limited-access location under the storage conditions specified on the IP supply label."
Colchicine-Placebo
Colchicine-Placebo tablet
RECRUITING
University of Calgary, Peter Lougheed Centre Vascular Clinic, Calgary
RECRUITING
University of Alberta, Mazankowski Heart Institute, Edmonton
RECRUITING
London Health Sciences Centre, London
RECRUITING
Vascular Health Bronte, Oakville
RECRUITING
Corcare Cardiovascular Research Inc., Scarborough Village
RECRUITING
Niagara Health System, St. Catharines
RECRUITING
Sunnybrook Research Institute, Toronto
RECRUITING
CIUSSS du Nord-de-l'île-de-Montréal, Hôpital du Sacré-Cœur-de-Montréal, Montreal
RECRUITING
University Hospital Basel, Angiology, Basel
RECRUITING
HFR Fribourg, Fribourg
RECRUITING
Hôpitaux Universitaires de Genève, Geneva
RECRUITING
University Hospital Zurich, Clinic of Angiology, Zurich
RECRUITING
Hamilton General Hospital, Hamilton
RECRUITING
Centre intégré de santé et de services sociaux du Bas-Saint-Laurent, Rimouski
Lead Sponsor
Population Health Research Institute
OTHER